MICA and recovery from hepatitis C virus and hepatitis B virus infections

Genes and Immunity

Volumn 5, Issue 4, 2004, Pages 261-266

  Karacki, P S ^a   Gao, X ^b   Thio, C L ^a   Thomas, D L ^a,b,h   Goedert, J J ^c   Vlahov, D ^a,d   Kaslow, R A ^e   Strathdee, S ^a   Hilgartner, M W ^f   O'Brien, S J ^g   Carrington, M ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NEW YORK ACADEMY OF MEDICINE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f WEILL CORNELL MEDICAL CENTER   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genetics; HBV; HCV; MICA; Pathogenesis; Viral persistence

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN DETECTION; ARTICLE; CHRONIC HEPATITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CONVALESCENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS;

HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; MICA;

EID: 3242663431     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364065     Document Type: Article

References (42)

1. World Health Organization. Hepatitis C: global prevalence. Weekly Epidemiol Rec 1997; 72: 341-348.
2. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-675.
3. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-1466.
4. Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999; 29: 908-914.
5. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999; 340: 1228-1233.
6. Muller R. The natural history of hepatitis C: clinical experiences. J Hepatol 1996; 24: 52-54.
7. Thomas DL, Astemborski J, Rai RM et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284: 450-456.
8. Thio CL, Gao X, Goedert JJ et al. HLA-Cw*04 and hepatitis C virus persistence. J Virol 2002; 76: 4792-4797.
9. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 1999; 354: 2119-2124.
10. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194: 1395-1406.
11. Rehermann B. Interaction between the hepatitis C virus and the immune system. Semin Liver Dis 2000; 20: 127-141.
12. Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 2002; 195: 43-49.
13. Crotta S, Stilla A, Wack A et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 2002; 195: 35-41.
14. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745.
15. Yang HI, Lu SN, Liaw YF et al. Hepatitis B antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-174.
16. Rehermann B, Fowler P, Sidney J et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995; 181: 1047-1058.
17. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997; 99: 1472-1477.
18. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995; 332: 1065-1069.
19. Hohler T, Gerken G, Notghi A et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol 1997; 26: 503-507.
20. Thio CL, Carrington M, O'Brien SJ et al. The association of HLA alleles and clearance of hepatitis B among African Americans. J Infect Dis 1999; 179: 1004-1006.
21. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994; 344: 1194-1195.
22. Verdon R, Pol S, Landais P et al. Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients. J Hepatol 1994; 21: 388-393.
23. Zavaglia C, Bortolon C, Ferrioli G et al. HLA typing in chronic type B, D and C hepatitis. J Hepatol 1996; 24: 658-665.
24. Van Hattum J, Schreuder GM, Schalm SW. HLA antigens in patients with various courses after hepatitis B virus infection. Hepatology 1987; 7: 11-14.
25. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000; 192: 921-930.
26. Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 2002; 16: 583-594.
27. Yokoyama WM, Plougastel BF. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003; 3: 304-316.
28. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727-729.
29. Steinle A, Li P, Morris DL et al. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 2001; 53: 279-287.
30. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998; 279: 1737-1740.
31. Tieng V, Le Bouguenec C, du ML et al. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci USA 2002; 99: 2977-2982.
32. Welte SA, Sinzger C, Lutz SZ et al. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 2003; 33: 194-203.
33. Wu J, Chalupny NJ, Manley TJ, Riddell SR, Cosman D, Spies T. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J Immunol 2003; 170: 4196-4200.
34. Jinushi M, Takehara T, Tatsumi T et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int J Cancer 2003; 104: 354-361.
35. Jinushi M, Takehara T, Kanto T et al. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J Immunol 2003; 170: 1249-1256.
36. Thio CL, Thomas DL, Karacki P. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003; 77: 12083-12087.
37. Vlahov D, Anthony JC, Muñoz A et al. The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J Drug Issues 1991; 21: 759-776.
38. Goedert JJ, Kessler CM, Aledort LM et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989; 321: 1141-1148.
39. Hilgartner MW, Donfield SM, Willoughby A et al. Hemophilia growth and development study. Design, methods, and entry data. Am J Pediatr Hematol Oncol 1993; 15: 208-218.
40. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126: 310-318.
41. Chmiel JS, Detels R, Kaslow RA, Van Raden M, Kingsley LA, Brookmeyer R. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol 1987; 126: 568-577.
42. Zhang Y, Lazaro AM, Lavingia B, Stastny P. Typing for all known MICA alleles by group-specific PCR and SSOP. Hum Immunol 2001; 62: 620-631.